Improve Medical(SZ:300030)2022-12-08 01:56Group 1: Product Performance - The overall growth of blood collection tube products is ongoing, but due to increased exports, the gross margin has declined, and the product's proportion is expected to decrease in the future [1] - Both self-produced and agency IVD products are increasing, and their future revenue will play a significant role [1] Group 2: Partnerships and Collaborations - The registration of products related to the partnership with Germany's ViraSense has been delayed, but the company is actively promoting progress and hopes to continue collaboration with the German side [1] - The company and its subsidiary, Ruida Medical, have obtained exclusive agency rights for Philips' basic medical products in South China, which will be distributed by distributors [1] Group 3: Future Directions - The company's future investment and acquisition direction will focus on five major product strategies: diagnosis, nursing anesthesia, imaging, pharmaceuticals, and health services [1] - The profit distribution plan and dividend strategy for the fiscal year 2014 have been announced and will be executed in accordance with relevant laws and regulations [1]